The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest
|
|
- Silvester Richards
- 5 years ago
- Views:
Transcription
1 The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest and Reperfusion on Myocardial Preservation John H. Rousou, M.D., Richard M. Engelman, M.D., William A. Dobbs, Ph.D., and Mooideen K. Meeran, M.D., Ph.D. ABSTRACT A study was undertaken to evaluate the effect of acute occlusion of a coronary artery during cardioplegic arrest on myocardial preservation and to elucidate the influence of reestablishment of flow versus continued occlusion during the phase of myocardial reperfusion. Coronary occlusion was simulated, and myocardial viability was determined by measuring tissue levels of adenosine triphosphate (ATP) and creatine phosphate (CP) in biopsies of the posterior left ventricular wall. Eighteen pigs were divided into three equal groups consisting of animals with (1) patent right coronary arteries during arrest, (2) occluded right coronary arteries during arrest and patent during reperfusion, and (3) occluded right coronary arteries during arrest. The results of ATP and CP measurements showed that while poorer protection was afforded during two-hour arrest when the coronary artery was occluded, the risk of damage was much greater during reperfusion. Failure to restore adequate blood flow by retention of occlusion caused a concurrent decrease in ATP and CP levels below prescribed limits of myocardial tolerance. When occlusion occurs in the clinical setting, impeding cardioplegia, the importance of revascularization is emphasized. Hypothermic potassium cardioplegia, when properly administered, safely protects the myocardium for up to two hours of ischemic arrest [l]. Potassium depolarization in conjunction with applied hypothermia minimizes degradation of high-energy phosphate compounds by sharply reducing aerobic glycolysis From the Departments of Surgery, University of Connecticut Health Center, Farmington, CT, and the Baystate Medical Center, Springfield, MA. Accepted for publication June 24, Address reprint requests to Dr. Rousou, Baystate Medical Center, 759 Chestnut St, Springfield, MA and decreasing the myocardial demand for oxygen [2, 31. Although sustained arrest are well tolerated by the myocardium under optimal conditions, the effect of acute coronary occlusion on preservation has not been well characterized. The pig heart was chosen as a model experimental system because of its lack of collateral circulation and its similarities to the human heart in response to acute ischemia [4, 51. A standard protocol was used to administer cold potassium cardioplegia during two hours of ischemic arrest [l]. A ligature placed near the origin of the right coronary artery was used to simulate the effect of an acute occlusion. The effect of vessel occlusion on high-energy phosphate levels during cardioplegic arrest was measured, and the results were compared with those from control animals with patent coronary arteries. This provides a comparable situation to that of cardioplegic arrest in the clinical setting when cardioplegia is not administered adequately into a coronary artery during arrest or when a distal coronary artery is inadvertently occluded during coronary sevascularization. Material and Methods Eighteen pigs weighing 17 to 24 kg underwent cardiopulmonary bypass using a perfusion circuit previously described [l]. In this preparation, the heart was isolated in its own perfusion circuit in situ, without perfusion of the rest of the animal (heart immersed in cold saline solution at 4 C). Following control studies in a normal beating heart, the animals underwent two hours of hypothermic cardioplegic arrest consisting of topical hypothermia and injection of a 50 ml bolus of cold (4 C) potassium cardioplegic solution to reach a myocardial temperature of 10" to 15 C. The composition of the solution was by The Society of Thoracic Surgeons
2 386 The Annals of Thoracic Surgery Vol 33 No 4 April 1982 as follows: 6% hydroxyethyl starch, 1 gmll of dextrose, 87 meqll of sodium chloride, 25 meq/l of sodium bicarbonate, and 35 meq/l of potassium chloride. Intramyocardial temperature was measured continuously in the septum but not in other areas of the myocardium. The osmolality of the solution was 350 mosm and the ph, 7.4 to 7.8. Fifty milliliters of the solution was administered into the aortic root, at 75 torr pressure, immediately following cessation of perfusion and every 15 minutes during arrest. During 30 minutes of reperfusion, myocardial temperature was promptly brought to 37 C by placing the heart in warm saline solution and using a normothermic perfusate. During this period the heart was defibrillated and a calibrated roller pump was used to maintain perfusion pressure at 75 torr. The animals were divided into three groups of 6 animals each. In control animals, patent coronary arteries permitted uninterrupted flow of perfusate during and after arrest. In the two experimental groups, the right coronary artery was occluded on the start of aortic crossclamping but prior to the administration of cardioplegia, by means of a ligature placed near the origin of the vessel in order to mimic the effect of acute coronary occlusion. The two experimental groups differed in that the ligature was maintained in one group during the arrest interval only and then was removed during reperfusion, while in the other group the vessel remained occluded throughout arrest. Metabolic Studies Each animal had biopsy samples 6 mm in diameter taken from the posterior wall of the left ventricle prior to arrest, at one hour and two hours of arrest, and after 30 minutes of reperfusion. Samples were removed by means of a modified dental drill. The tissue was immediately cooled in liquid nitrogen. No attempt was made to close the biopsy sites. The frozen tissue-biopsy was weighed on a torsion balance at 20 C and then pulverized in a cooled mortar with frozen 0.6 N perchloric acid. The resultant powder was thawed in an iced acetone bath at O'C, and a perchloric acid extract was obtained by centrifugation. The extract was neutralized and brought to 10 ml. Adenosine triphosphate (ATP) and creatine phosphate (CP) levels were determined by the colorimetric method of Lamprecht and Trautschold [6]. Statistical Methods Statistical analysis was performed using the two-sample Student's t test. Significance of differences was established when the p value was less than or equal to Results are presented for each treatment group as the mean plus or minus the standard error of the mean. Results Adenosine Triphosphate The levels of ATP measured in myocardial tissue of the three animal groups are listed in the Table and are represented graphically in Figure 1. They were found to be directly related to the presence of arterial occlusion. In control animals, ATP levels during arrest increased slightly to 109% of prearrest levels (from 4.04 to a mean value of 4.46 pmolelgm wet weight), supporting observations of a previous study [l]. After two hours of arrest, the control ATP was significantly higher (p < 0.01) than that obtained from either occluded group (4.46 f 0.31 versus 3.14 f 0.09 and 3.16 f 0.27 pmolelgm wet weight). With coronary arterial occlusion during arrest, ATP levels in the two experimental groups decreased gradually to final measurements of 89.4 and 82.2% of prearrest levels (from 3.56 to 3.14 and from 3.84 to 3.16 pmolelgm wet weight, respectively). The response of ATP to reperfusion, regardless of arterial occlusion, was to decrease from the levels measured before arrest. The difference between the measurements obtained before arrest and after reperfusion were significant in all three groups (p < 0.05), but the most dramatic difference was noted with the persistence of occlusion during the reperfusion period. The level of ATP was significantly lower (p < 0.01) in the occluded group than in either of the other two groups (see Fig 1). The mean level after reperfusion was highest in control animals at 85.7% of the prearrest level (3.12 pmolelgm wet weight). Removal of the ligature in one of the experimental groups, permitting reperfusion, allowed ATP to decrease only to
3 387 Rousou et al: Coronary Artery Occlusion and Myocardial Preservation Levels of Adenosine Triphosphate and Creatine Phosphate in Biopsies of Posterior Left Ventricular Wall Arrest Prearrest Reperfusion Groups Control 1 Hour 2 Hours 30 Minutes ADENOSINE TRIPHOSPHATE RCA patent during arrest 4.04 f f f f 0.22 RCA occluded during arrest, 3.56 f f f f 0.16 patent during reperfusion RCA occluded during arrest 3.84 * f f * 0.27 CREATINE PHOSPHATE RCA patent during arrest 7.88 f f f f 0.66 RCA occluded during arrest, 7.45 f f f * 0.45 RCA occluded during arrest patent during reperfusion 7.47 f f f f 0.36 adata shown as mean k standard error of the mean and measured in pmole/gm wet weight. RCA = right coronary artery 77.4% of prearrest levels (2.75 pmolelgm wet weight) and not differ significantly from control. Retention of the ligature effected a significantly greater (p < 0.01) reduction to 43% of prearrest levels (1.70 pmolelgm wet weight). Creatine Phospate Comparative CP levels during arrest are listed in the Table and are graphed in Figure 2. Regardless of arterial occlusion, all animals exhibited significant (io < 0.01) decreases in tissue levels of CP from prearrest values to one- and two-hour time points. After one hour of arrest, levels were reduced to 60% of prearrest in control animals (from 7.88 to 4.67 pmolelgm wet weight). In the two groups with occlusion, CP levels fell to 32.6% (from 7.45 to 2.32 pmolelgm wet weight and to 46.4% (from 7.47 to 3.53 pmolelgm wet weight) after one hour. Measurements taken after two hours of arrest showed an additional 6% decrease (from 4.67 to 4.06 pmolelgm wet weight) in control animals, while significantly greater reductions (io < 0.05) were observed when coronary arteries were occluded. Final mean percentage levels of CP after two hours of arrest were 17.8% of control in one experimental group (from 7.45 to 1.28 pmolelgm wet weight) and 29.7% in the other (from 7.47 to 2.04 pmolelgm wet weight). The difference between the control group and both occluded groups is significant (p < 0.01) at two hours of arrest. After 30 minutes of reperfusion, CP levels returned to the range of prearrest levels only in the absence of arterial occlusion. Animals in which the coronary arterial ligature was retained had significantly (p < 0.01) depressed levels of CP compared with the groups with patent arteries. Values in control animals approximated prearrest levels (99.3%), as did those in animals in which occlusion was present only during the arrest period (94.4%). In contrast, arterial occlusion during reperfusion kept CP levels well below normal at 51.9% of prearrest levels. Comment Myocardial viability following sustained ischemic arrest has been directly correlated with levels of high-energy phosphates utilized in aerobic and anaerobic metabolism, namely All and CP [7-91. The ability of the heart to recover after an ischemic insult will depend not only on the preservation
4 388 The Annals of Thoracic Surgery Vol 33 No 4 April 1982 T 0 I I I I \ \j Preorrest 60 min 120 min 30 min Control Reperfusion ARREST Fig 1. Effect of occlusion of the right coronary artery (RCA) on the adenosine triphosphate (ATP) level during and following two-hour cardioplegic arrest and 30-minute reperfusion. Potent RCA during Arrest - Potent RCA during Reperfusion Patent RCA during Reperfusion - -A Occluded RCA during Reperfusion T T 0 I I I I Prearresl 60 min I20 min 30 rnin Control Reperfusion ARREST Fig 2. Effect of occlusion of the right coronary artery (RCA) on the creatine phosphate (CP) level during and after cardioplegic arrest. - Pafent Potent RCA during Arrest - ' Patent RCA during Reperfusion RCA during Reperfurion --A Occluded RCA during Reperfuslon
5 389 Rousou et al: Coronary Artery Occlusion and Myocardial Preservation during ischemia, but also the regeneration of high-energy phosphates in the reperfused myocardium. A drop in the ATP content to less than 35 to 40% of preischemic levels will cause irreversible damage synonymous with myocardial necrosis [3, 7, 103. The effectiveness of a cardioplegic agent in protecting the myocardium during ischemia, therefore, can be measured by its ability to preserve the high-energy stores. To achieve this the cardioplegic solution has to gain access to the myocardial cell through the coronary capillary bed, either through its primary feeding artery or through collateral vessels in case of coronary stenosis. Use of hypothermic potassium cardioplegia under optimal conditions with nonobstructed coronary flow minimizes degradation of highenergy phosphates and affords myocardial preservation for up to two hours of ischemic arrest [l]. The presence of acute coronary occlusion, however, can hamper the effectiveness of the cardioplegic agent in protecting the myocardium by limiting adequate contact of the agent with myocardial tissue in the affected region. This has been clearly demonstrated by Hilton and associates in a study in dogs [ll]. They demonstrated metabolic as well as hemodynamic evidence of suboptimal myocardial protection afforded by the cardioplegic agent in regions of coronary occlusion. In our experiment, the impact of acute coronary occlusion was measured on myocardial high-energy phosphates present during the ischemic interval and during the period of reperfusion in a setting simulating inadequate myocardial protection and persistent acute coronary artery occlusion. The acute coronary artery occlusion, especially in areas of inadequate collateral flow, limits the access of cardioplegic solution to the myocardium during the ischemic interval and if not corrected or bypassed, also prevents the restoration of adequate coronary blood flow immediately following the arrest interval. It has already been demonstrated that prevention of adequate exposure of the myocardium to the cold cardioplegic solution leads to increased degradation of high-energy phosphates and poor preservation during ischemic arrest [ll]. We carried the same line of thought one step further into the reperfusion period, to elucidate the consequences of acute coronary occlusion with incomplete revascularization. We recognize and emphasize that this model has some dissimilarities to the clinical setting in the operating room, mainly in regard to the absence of collateral vessels in the pig myocardium. The presence of collaterals in the human heart, however, if indeed present in the underperfused area of myocardium, does not ensure safety, as they may not function in an acute OCclusion in contradistinction to a slow and chronic narrowing of the artery. Collateral protection is, of course, a variable even in human hearts, and this experiment emphasizes one end of this spectrum-the extreme-to bring out the point to be made. In the clinical setting, acute coronary occlusion could occur in a number of instances with resulting myocardial damage similar to what was found in this experiment. In aortic valve replacement, for example, failure to cannulate one coronary artery in the left system because of a short or nonexistent left main coronary artery would result in inadequate myocardial protection much like the second group in which the ligature was present only during the arrest period. On the other hand, a persistent coronary embolus, endothelial damage, or other acute and persistent mechanical coronary occlusion during arrest would result in the very poor myocardial protection seen in the third experimental group in which the ligature was left on through reperfusion. Previous work in our laboratory demonstrated that reperfusion through the normal coronary bed returns CP to normal preischemic levels (100%) and ATP to near normal levels (89.4%), much like the control group in this study (99.3 and 85.7% for CP and ATP, respectively). However, the inability of hypoperfused myocardium to regenerate its energy stores to normal or near normal levels during reperfusion is clearly demonstrated. Both groups with a nonoccluded right coronary artery during reperfusion regenerated the ATP and CP to near normal levels (85.7% and 77.4%, ATP, and 99.3% and 94.4%, CP) while the group with an
6 390 The Annals of Thoracic Surgery Vol 33 No 4 April 1982 occluded right coronary artery showed significantly lower ATP and CP levels (43.7% and 51.9'/0, respectively). These data support our main contention that unrecognized and acute unrelieved coronary occlusion will compromise myocardial protection not only during the ischemic period, by barring access of the cardioplegic agent to myocardial cells, but more importantly during reperfusion by inhibiting adequate highenergy phosphate regeneration. Therefore, in the clinical setting, optimal myocardial protection depends on two major factors. The first is the access of the cardioplegic agent to the myocardial cell in order to minimize the effects of ischemia, and the second is the completeness of reperfusion to ensure reversal of the existing effects of ischemia, the latter being obviously more critical. The surgeon must adopt techniques and means to achieve these two ends, namely, optimal preservation during ischemia and optimal recovery during reperfusion. For example, during aortic valve replacement in a patient with a short left main coronary artery, it is important to cannulate both the left anterior descending and circumflex coronary arteries individually to avoid a situation analogous to the second group in this experiment. Air emboli must be avoided to prevent acute occlusion of coronary arteries and insufficient myocardial preservation or reperfusion or both. Measurement of flow in coronary grafts should be performed, as it will detect obstructive anastomoses that will prevent adequate reperfusion. Probing low-flow grafts sometimes helps to identify technical errors in the anastomoses or to disperse an obstructive air embolus. Finally, we prefer to perform the proximal anastomoses first and then, during the arrest period, to revascularize the warmest areas of the myocardium first so that cardioplegic solution administered between anastomoses can reach these areas of the heart early. These and perhaps other techniques constitute the fine points of myocardial revascularization that will affect preservation of function for immediate and long-term cardiac performance. Supported by Grant 1 R01 HL A1 from the National Institutes of Health and Grant from the American Heart Association. Assistance in the preparation of this manuscript was provided by Mrs. Jamie L. Banks. References 1. Engelman RM, Rousou JH, Longo F, et al: The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest. Surgery 86:138, Levitsky S, Wright RN, Rao KS, et al: Does intermittent coronary perfusion offer greater myocardial protection than continuous aortic cross-clamping? Surgery 82:5159, Lochner W, Arnold G, Muller-Rucholtz ER: Metabolism of the artificially arrested heart and of the gas perfused heart. Am J Cardiol 22:299, Bustad LK (ed): Swine in Biochemical Research: Proceedings of a Symposium at the Pacific Northwest Laboratories, Richland, WA, July 19-22, Richland, WA, Batelle Memorial Institute, Engelman RM, Auvil J, O'Donoghue MN, et al: The significance of normothermic anoxic arrest and ventricular fibrillation on the coronary blood flow distribution of the pig. J Thorac Cardiovasc Surg , Lamprecht W, Trautschold J: Determination with hexokinase and glucose-6-phosphate dehydrogenase. In Bergmeyer U (ed): Methods of Enzymatic Analysis. New York, Academic, 1965, pp 543, Hearse DJ, Stewart DA. Chain EB: Recovery from cardiac bypass and elective cardiac arrest: the metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res 35:448, Rao KS, Levitsky S, Holland C, et al: Does potassium chloride-induced cardiac arrest protect the myocardium during aortic cross-clamping? Surg Forum 27:262, Wollenberg A, Krause EG: Metabolic control characteristics of the acutely ischemic myocardium. Am J Cardiol 22:349, Lungsgaahd-Hansen P: Surgical aspects of cardiac metabolism (collective review). Surg Gynecol Obstet 122:1095, Hilton CJ, Teubl W, Acker M, et al: Inadequate cardioplegic protection with obstructed coronary arteries. Ann Thorac Surg 28:323, 1979
Demonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationTopical Cardiac Cooling by Recirculation: Comparison of a Closed System Using a Cooling Pad
Topical Cardiac Cooling by Recirculation: Comparison of a Closed System Using a Cooling Pad with an Open System Using a Topical Spray Franklin L. Rosenfeldt, M.D., F.R.C.S.E., and Malcolm Arnold, M.B.,
More informationocclusions. Cerebral perfusion is driven fundamentally by regional cerebral
Appendix Figures Figure A1. Hemodynamic changes that may occur in major anterior circulation occlusions. Cerebral perfusion is driven fundamentally by regional cerebral perfusion pressure (CPP). In response
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationSaphenous Vein Autograft Replacement
Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion Operative Technique Rene G. Favaloro, M.D. D irect operation on the coronary artery has been performed in 180 patients
More informationThe Preservation of a Traumatically Amputated Limb Utilizing Crystalloid Cardioplegia Solution-A Case Report
PROCEEDINGS The Preservation of a Traumatically Amputated Limb Utilizing Crystalloid Cardioplegia Solution-A Case Report William G. Maurer, Louie C. Wilson, William R. Higgs, John E. Stone, Thomas J. Gibson,
More informationMYOCARDIAL REPERFUSION
ALLOPURINOL IMPROVES MYOCARDIAL REPERFUSION INJURY IN A XANTHINE OXIDASE FREE MODEL Steven B. Hopson, MD, Robert M. Lust, PhD, You Su Sun, MD, Richard S. Zeri, MD, Ron F. Morrison, Masaki Otaki, MD, and
More informationmyocardial protection. during Prolonged Aortic Cross-Clamping wih Cold Blood Potassium Cardioplegia
Mvocardial Protection wih Cold Blood Potassium Cardioplegia during Prolonged Aortic Cross-Clamping Frank P. Catinella, M.D., Joseph N. Cunningham, Jr., M.D., Peter X. Adams, M.D., Steven L. Snively, M.D.,
More informationIntraoperative Myocardial Protection: Current Trends and Future Perspectives
Intraoperative Myocardial Protection: Current Trends and Future Perspectives Gideon Cohen, MD, Michael A. Borger, MD, Richard D. Weisel, MD, and Vivek Rao, MD, PhD Division of Cardiovascular Surgery, The
More informationfor Improved Topical Car & ac Hypothermia
A Recirtrulating Cooling S stem for Improved Topical Car & ac Hypothermia F. L. Rosenfeldt, F.R.C.S.E., A. Fambiatos, B.Sc., J. PastorizaPinol, C.C.P., and G. R. Stirling, F.R.A.C.S. ABSTRACT A simple
More informationand Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.
Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular
More informationIs Reperfusion Injury from Multiple Aortic Cross-Clamping a Current Myth of Cardiac Surgery?
ORIGINAL ARTICLES Is Reperfusion Injury from Multiple Aortic Cross-Clamping a Current Myth of Cardiac Surgery? David M. Lolley, M.D., Jefferson F. Ray, 111, M.D., William 0. Myers, M.D., Richard D. Sautter,
More informationF rent techniques of hypothermic cardioplegic arrest
Does Hypothermic Fibrillatory Arrest Improve Myocardial Protection During Emerrrencv Revascularization? U J Peter S. Greene, MD, Duke E. Cameron, MD, Elaine M. Griffiths, MB, Joseph M. DiNatale, BS, and
More informationof Cardioplegia: Assessment by Thermovision N. Shapira, M.D., G. M. Lemole, M.D., P. M. Spagna, M.D., F. J. Bonner, M.D.,
Antegrade and Infusion of Cardioplegia: Assessment by Thermovision N. Shapira, M.D., G. M. Lemole, M.D., P. M. Spagna, M.D., F. J. Bonner, M.D., J. Fernandez, M.D., and D. Morse, M.D. ABSTRACT The efficacy
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationThe arterial switch operation has been the accepted procedure
The Arterial Switch Procedure: Closed Coronary Artery Transfer Edward L. Bove, MD The arterial switch operation has been the accepted procedure for the repair of transposition of the great arteries (TGA)
More informationEffect of Sodium Nitroprusside during the Payback Period of Cardiopulmonary Bypass on the Incidence of Postoperative Arrhythmias
Effect of Sodium Nitroprusside during the Payback Period of Cardiopulmonary Bypass on the Incidence of Postoperative Arrhythmias Kit V. Arom, M.D., David M. Angaran, M.S., William G. Lindsay, M.D., William
More informationAcute type A aortic dissection (Type I, proximal, ascending)
Acute Type A Aortic Dissection R. Morton Bolman, III, MD Acute type A aortic dissection (Type I, proximal, ascending) is a true surgical emergency. It is estimated that patients suffering this calamity
More informationof Potassium ~ardiopbgic Solution
Comparison of Roller Pump versus Pressurized Bag Administration of Potassium ~ardiopbgic Solution Frederick L. Grover, M.D., John G. Fewel, M.S., John J. Ghidoni, M.D., Edward V. Bennett, Jr., M.D., and
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationTechniques of preservation and storage of the donor
Continuous Perfusion Improves Preservation of Donor Rat Hearts: Importance of the Implantation Phase David K. Nickless, MB, BS, Marc Rabinov, MB, BS, PhD, Stephen M. Richards, PhD, Robert A. J. Conyers,
More informationThank you, chairpersons. Ladies and gentlemen, it is a great honor to have this opportunity to report and discuss the current status of off-pump CABG
Thank you, chairpersons. Ladies and gentlemen, it is a great honor to have this opportunity to report and discuss the current status of off-pump CABG in Japan. And again. I would like to thank Dr Puskas
More informationFurthermore, potassium arrest appears to be more protective than coronary perfusion at 28 C.
The Importance of Hyperkalemia in a Cold Perfusion Solution: A Correlative Study Examining Myocardial Function, Metabolism, Tissue Gases, and Substrates William H. Heydorn, M.D., Col, MC, USA, William
More informationDisease of the aortic valve is frequently associated with
Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities
More informationdelnido for Myocardial Protection
delnido for Myocardial Protection Linda B. Mongero, CCP Director of Education and Clinical Performance IV.PERFUSION SYMPOSIUM 3-5 NOVEMBER 2017 TİTANİC HOTEL LARA, ANTALYA IV.PERFUSION SYMPOSIUM 2017 No
More informationAP2 Lab 3 Coronary Vessels, Valves, Sounds, and Dissection
AP2 Lab 3 Coronary Vessels, Valves, Sounds, and Dissection Project 1 - BLOOD Supply to the Myocardium (Figs. 18.5 &18.10) The myocardium is not nourished by the blood while it is being pumped through the
More informationOPCABG for Full Myocardial Revascularisation How we do it
OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More informationIn 1980, Bex and associates 1 first introduced the initial
Technique of Aortic Translocation for the Management of Transposition of the Great Arteries with a Ventricular Septal Defect and Pulmonary Stenosis Victor O. Morell, MD, and Peter D. Wearden, MD, PhD In
More informationAcid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation
Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation Michael Kremke Department of Anaesthesiology and Intensive Care Aarhus University Hospital, Denmark
More informationT techniques during cardiac operations has been to
Warm Heart Surgery and Results of Operation Recent Myocardial Infarction Samuel V. Lichtenstein, MD, PhD, James G. Abel, MD, and Tomas A. Salerno, MD Division of Cardiovascular Surgery, St. Michael's Hospital
More informationResults of Reoperation
Results of Reoperation for Recurrent Angina Pectoris William I. Norwood, M.D., Lawrence H. Cohn, M.D., and John J. Collins, Jr., M.D. ABSTRACT Although a coronary bypass operation improves the quality
More informationCritical coronary stenoses may limit the delivery of OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA
OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA Vivek Rao, MD Gideon Cohen, MD Richard D. Weisel, MD Noritsugu Shiono, MD, PhD Yoshiki Nonami, MD, PhD Susan M. Carson, AHT Joan Ivanov, RN, MSc Michael A.
More informationStable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology
Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationRole of Myocardial Temperature Measurement in Monitoring the Adequacy of Myocardial Protection During Cardiac Surgery
Role of Myocardial Temperature Measurement in Monitoring the Adequacy of Myocardial Protection During Cardiac Surgery Joseph A. Dearani, MD, Trevor C. Axford, MD, Manisha A. Patel, MD, Nancy A. Healey,
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationMirsad Kacila*, Katrin Schäfer, Esad Subašić, Nermir Granov, Edin Omerbašić, Faida Kučukalić, Ermina Selimović-Mujčić
& Influence of Two Different Types of Cardioplegia on Hemodilution During and After Cardiopulmonary Bypass, Postoperative Chest-Drainage Bleeding and Consumption of Donor Blood Products Mirsad Kacila*,
More informationComparison of Flow Differences amoiig Venous Cannulas
Comparison of Flow Differences amoiig Venous Cannulas Edward V. Bennett, Jr., MD., John G. Fewel, M.S., Jose Ybarra, B.S., Frederick L. Grover, M.D., and J. Kent Trinkle, M.D. ABSTRACT The efficiency of
More informationChoice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke
The Journal of The American Society of Extra-Corporeal Technology Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke Yasuyuki Shimada, MD, PhD;* Hitoshi Yaku,
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationPreconditioning is defined as the cardioprotective effects
Preconditioning Prevents Myocardial Stunning After Cardiac Transplantation Roderick W. Landymore, MD, Alexander J. Bayes, MD, J. Thomas Murphy, MD, and John H. Fris, RT King Fahad National Guard Hospital,
More informationFurther Studies on the Effect of Arteriovenous Fistulas and Elevations of Sinus Pressure
Further Studies on the Effect of Arteriovenous Fistulas and Elevations of Sinus Pressure on Mortality Rates Following Acute Coronary Occlusions By GEORGE SMITH, F.R.C.S., JAMES DEMMING, MORTON ELEFF, AND
More informationThe Groningen hypothermic liver perfusion system for improved preservation in organ transplantation Plaats, Arjan van der
University of Groningen The Groningen hypothermic liver perfusion system for improved preservation in organ transplantation Plaats, Arjan van der IMPORTANT NOTE: You are advised to consult the publisher's
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationAcute heart failure: ECMO Cardiology & Vascular Medicine 2012
Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart
More informationNeurologic Events After Coronary Bypass Grafting: Further Observations With Warm Cardioplegia
Neurologic Events After Coronary Bypass Grafting: Further Observations With Warm Cardioplegia Joseph M. Craver, MD, Bradley L. Bufkin, MD, William S. Weintraub, MD, and Robert A. Guyton, MD Division of
More informationLeft Ventricular Subendocardial Necrosis
COLLECTIVE REVIEW Left Ventricular Subendocardial Necrosis Gerald D. Buckberg, M.D. ABSTRACT The hearts of as many as 90% of patients who die after open-heart operations have left ventricular subendocardial
More informationManagement during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography
Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper
More informationGlobal Myocardial Protection
Global Myocardial Protection Edwards offers a wide range of antegrade and retrograde cardioplegia products designed to promote global myocardial protection. Complete Antegrade/Retrograde Solutions Edwards
More informationwith Fluosol Cardioplegia
Optimal Myocardial Protection with Fluosol Cardioplegia George J. Magovern, Jr., M.D., John T. Flaherty, M.D., Vincent L. Gott, M.D., Bernadine H. Bulkley, M.D., and Timothy J. Gardner, M.D. ABSTRACT An
More informationCoronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates
Coronary arteriography in complicated acute myocardial ; clinical and angiographic correlates Luis M. de la Fuente, M.D. Buenos Aires, Argentina From January 1979 to June 30, 1979, we performed coronary
More informationExperimental Comparison of Shumway s Technique and Perfusion Cooling
111. Local Cardiac Hypothermia: Experimental Comparison of Shumway s Technique and Perfusion Cooling F. L. Rosenfeldt, F.R.C.S.E., and D. A. Watson, F.R.C.S. ABSTRACT A model of the thermal conditions
More informationEnhanced CABG is in Your Hands
An Intraoperative Treatment for Preserving Vascular Grafts Enhanced CABG is in Your Hands Intraoperative Graft Damage is the Principal Cause of Vein Graft Failure (VGF) The durability and patency of vein
More informationASSESSING PATIENTS FOR CORONARY ARTERY BYPASS SURGERY INTRODUCTION
THERAPEUTIC UPDATE ASSESSING PATIENTS FOR CORONARY ARTERY BYPASS SURGERY B L Chia LKATan INTRODUCTION Coronary artery disease is today one of the most important causes of deaths in our community (1). The
More informationCoronary artery bypass grafting (CABG) without an
Coronary Artery Bypass Grafting on the Beating Heart Evaluated With Integrated Backscatter Kenichi Imasaka, MD, Shigeki Morita, MD, Ichiro Nagano, MD, Munetaka Masuda, MD, Ryuji Tominaga, MD, and Hisataka
More informationMB Creatine Kinase and the Evaluation of Myocardial Injury Following Aortocoronary Bypass Operation
MB Creatine Kinase and the Evaluation of Myocardial Injury Following Aortocoronary Bypass Operation Claude du Cailar, M.D., Jean-Guy Maillk, M.D., William Jones, M.D., B. Charles Solymoss, M.D., Michel
More informationCalcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium
Calcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium E. Jack Baker IV, MD, Gordon N. Olinger, MD, and John E. Baker, PhD Department of Cardiothoracic Surgery, Medical
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationGoing on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia
Going on Bypass What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia Circulation Brain Liver Kidneys Viscera Muscle Skin IVC, SVC Pump Lungs R.A. L.V.
More informationMyocardial Protection During Antegrade Versus Retrograde Cardioplegia
Myocardial Protection During Antegrade Versus Retrograde Cardioplegia Päivi K. Kaukoranta, MD, Martti V. K. Lepojärvi, MD, Kai T. Kiviluoma, MD, PhD, Kari V. Ylitalo, MD, and Keijo J. Peuhkurinen, MD,
More informationIncreasing Organ availability: From Machine Perfusion to Donors after Cardiac Death. Ayyaz Ali
Increasing Organ availability: From Machine Perfusion to Donors after Cardiac Death Ayyaz Ali No relevant financial disclosures 2 Heart Transplantation - Activity 3 Donor Heart Preservation Static preservation
More informationPerfusion for Repair of Aneurysms of the Transverse Aortic Arch
technique This new section is open for technicians to explore the unusual, the difficult, the innovative methods by which perfusion meets the challenge of the hour and produces the ultimate goal - a life
More informationRyuzo Bessho, MD * David J. Chambers, PhD
EXPERIMENTAL STUDY OF INTERMITTENT CROSSCLAMPING WITH FIBRILLATION AND MYOCARDIAL PROTECTION: REDUCED INJURY FROM SHORTER CUMULATIVE ISCHEMIA OR INTRINSIC PROTECTIVE EFFECT? Ryuzo Bessho, MD * David J.
More informationEffects of Cardioplegic Solution on Human Contractile Element Velocity
ORIGINAL ARTICLES Effects of Cardioplegic Solution on Human Contractile Element Velocity Douglas M. Behrendt, M.D., Marvin M. Kirsh, M.D., Kenneth E. Jochim, Ph.D., and Herbert Sloan, M.D. ABSTRACT A technique
More informationComparison of the Protective Properties of Four
Comparison of the Protective Properties of Four Clinical Crystalloid Cardioplegic Solutions in the Rat Heart Lary A. Robinson, M.D., Mark V. Braimbridge, F.R.C.S., and David J. Hearse, D.Sc. ABSTRACT Although
More informationEffects of an Abdominal Left Ventricular Assist Device on Myocardial Oxygen Supply /Demand Ratios in Normallv Perfused and Ischemic Bovine Myocardium
Effects of an Abdominal Left Ventricular Assist Device on Myocardial Oxygen Supply /Demand Ratios in Normallv Perfused and Ischemic Bovine Myocardium David A. Hughes, M.D., Stephen R. Igo, Benedict D.
More informationCold Blood as the Vehicle for Potassium Cardioplegia
Cold Blood as the Vehicle for Potassium Cardioplegia Hendrick B. Barner, M.D., Hillel Laks, M.D., John E. Codd, M.D., John W. Standeven, Ph.D., Max Jellinek, Ph.D., George C. Kaiser, M.D., Leo J. Menz,
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationDistal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty
Distal Coronary rtery Dissection Following Percutaneous Transluminal Coronary ngioplasty Douglas. Murphy, M.D., Joseph M. Craver, M.D., and Spencer. King 111, M.D. STRCT The most common cause of acute
More informationAnatomic variants of the normal coronary artery circulation
Diagnosis and Operation for Anomalous Circumflex Coronary Artery Keishi Ueyama, MD, PhD, Mahesh Ramchandani, MD, Arthur C. Beall, Jr, MD, and James W. Jones, MD, PhD Department of Surgery, Baylor College
More informationUniversity of Groningen. Impaired Organ Perfusion Morariu, Aurora
University of Groningen Impaired Organ Perfusion Morariu, Aurora IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document
More informationin Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.
Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative
More informationApplication of Multivariate Analysis to the Enzvme Patterns in the Serum of Patients Undergoiig Coronary Artery Operation
Application of Multivariate Analysis to the Enzvme Patterns in the Serum of Patients Undergoiig Coronary Artery Operation L. Dieter Voegele, M.D., Alan J. Gross, Ph.D., William H. Prioleau, Jr., M.D.,
More informationAcute chest pain and ECG need for immediate coronary angiography?
Acute chest pain and ECG need for immediate coronary angiography? Kjell Nikus, MD, PhD Heart Center, Tampere University Hospital, Finland and Samuel Sclarovsky, MD, PhD Tel Aviv University, Israel There
More informationWarm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery
Nardi et al. Cell Death Discovery DOI 10.1038/s41420-018-0031-z Cell Death Discovery ARTICLE Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery
More informationTechnical Aspects of Simultaneous Antegrade/Retrograde Normothermic Blood Cardioplegia
Technique Technical Aspects of Simultaneous Antegrade/Retrograde Normothermic Blood Cardioplegia Zahir Young, ACP, CPC; Maija Saikkonen, CPC; Tessa Tam, CPC, CCP; Aido Ko, CPC, CCP St. Michael's Hospital,
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationCardiovascular System Notes: Heart Disease & Disorders
Cardiovascular System Notes: Heart Disease & Disorders Interesting Heart Facts The Electrocardiograph (ECG) was invented in 1902 by Willem Einthoven Dutch Physiologist. This test is still used to evaluate
More informationM myocardial preservation [l], and may act by antagonizing
Myocardial Preservation Related to Magnesium Content of Hyperkalemic Cardioplegic Solutions at 8 C Tommy R. Reynolds, MD, Gillian A. Geffin, MB, BS, James S. Titus, Dennis D. O Keefe, MD, and Willard M.
More informationLimiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions
Limiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions Harold L. Lazar, MD, X. Zhang, MD, Samuel Rivers, BS, Sheilah Bernard, MD, and Richard J. Shemin, MD Department of Cardiothoracic
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationMechanical Bleeding Complications During Heart Surgery
Mechanical Bleeding Complications During Heart Surgery Arthur C. Beall, Jr., M.D., Kenneth L. Mattox, M.D., Mary Martin, R.N., C.C.P., Bonnie Cromack, C.C.P., and Gary Cornelius, C.C.P. * Potential for
More informationValue of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting
Thorax 1983;38:946-95 Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting RICHARD W BUNTON From the Department of Cardiothoracic
More informationMyocardial Protection Principles. David J Chambers
David J Chambers Cardiac Surgical Research/Cardiothoracic Surgery The Rayne Institute (King s College London) Guy s & St Thomas NHS Foundation Trust St Thomas Hospital London UK ScanSect, Aarhus, Denmark.
More informationThe contemporary results of coronary artery bypass
INSULIN CARDIOPLEGIA FOR ELECTIVE CORONARY BYPASS SURGERY Vivek Rao MD, PhD Michael A. Borger, MD Richard D. Weisel, MD Joan Ivanov, RN George T. Christakis, MD Gideon Cohen, MD Terrence M. Yau, MD For
More informationPercutaneous Mitral Valve Intervention: QuantumCor Device
Percutaneous Mitral Valve Intervention: QuantumCor Device RICHARD R. HEUSER, MD, FACC, FACP, FESC Director Of Cardiology, St. Luke s Medical Center, Phoenix, Arizona Medical Director, Phoenix Heart Center,
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationANTEGRADE AND RETROGRADE CARDIOPLEGIA: ALTERNATE OR SIMULTANEOUS?
ANTEGRADE AND RETROGRADE CARDIOPLEGIA: ALTERNATE OR SIMULTANEOUS? Toshizumi Shirai, MD Vivek Rao, MD Richard D. Weisel, MD John S. Ikonomidis, MD, PhD Nobuhiko Hayashida, MD Joan Ivanov, RN, MSc Susan
More informationadministration of adrenaline or in cases of increased perfusion pressure. approximately the same within fairly wide variations of the systemic
6I2. I72. I THE DISTRIBUTION OF THE BLOOD IN THE CORONARY BLOOD VESSELS. BY G. V. ANREP, A. BLALOCK AND M. HAMMOUDA. (From the Physiological Laboratory, Cambridge.) As a result of experiments on perfused
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationEffects of myocardial infarction on catheter defibrillation threshold
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1983 Effects of myocardial infarction on catheter defibrillation threshold
More information